Neil

NBC News' Kristen Welker to Accept 2023 National Press Club Fourth Estate Award

Retrieved on: 
Thursday, August 31, 2023

WASHINGTON, Aug. 31, 2023 /PRNewswire/ -- Kristen Welker , NBC News chief White House correspondent and incoming moderator of "Meet the Press," will receive the National Press Club's Fourth Estate Award during a gala in her honor on Nov. 28 in Washington.

Key Points: 
  • WASHINGTON, Aug. 31, 2023 /PRNewswire/ -- Kristen Welker , NBC News chief White House correspondent and incoming moderator of "Meet the Press," will receive the National Press Club's Fourth Estate Award during a gala in her honor on Nov. 28 in Washington.
  • The Fourth Estate is the top honor bestowed on a journalist by the National Press Club Board of Governors.
  • "
    This year's Fourth Estate gala will also commemorate a Club milestone: The Fourth Estate Award is now in its 50th year.
  • For information on sponsorship opportunities please email Beth Francesco, executive director of the National Press Club Journalism Institute, at [email protected] .

ZyVersa Therapeutics Reports Second Quarter 2023 Corporate and Financial Results

Retrieved on: 
Monday, August 21, 2023

WESTON, Fla., Aug. 21, 2023 (GLOBE NEWSWIRE) -- ZyVersa Therapeutics, Inc. (Nasdaq-GM: ZVSA; “ZyVersa”), a clinical stage specialty biopharmaceutical company developing first-in-class drugs for treatment of patients with renal and inflammatory diseases who have unmet medical needs, today provides a corporate update and reports financial results for the second quarter of 2023 ending June 30, 2023.

Key Points: 
  • “The second quarter of 2023 was a period of continued progress at ZyVersa as we completed key corporate, developmental, regulatory and financial initiatives designed to position the company to achieve value-building milestones involving our Cholesterol Efflux Mediator™ VAR 200 and Inflammasome ASC Inhibitor IC 100,” said Stephen C. Glover, Co-founder, Chairman, Chief Executive Officer, and President of ZyVersa.
  • “We are pleased to report our VAR 200 program is progressing as planned, and we anticipate initiation of a Phase 2a clinical trial in diabetic kidney disease (DKD) in the first quarter of 2024.
  • The increase is primarily attributable to an increase of $0.5 million in the costs of manufacturing of IC 100.
  • The impairment is a result of the decline in ZyVersa’s market capitalization as of June 30, 2023.

Kat Stafford of The Associated Press honored with Sheehan award for investigative journalism from National Press Club Journalism Institute

Retrieved on: 
Tuesday, August 8, 2023

WASHINGTON, Aug. 8, 2023 /PRNewswire/ -- Kat Stafford , a national investigative writer with The Associated Press, will receive the National Press Club Journalism Institute's 2023 Neil and Susan Sheehan Award for Investigative Journalism.

Key Points: 
  • WASHINGTON, Aug. 8, 2023 /PRNewswire/ -- Kat Stafford , a national investigative writer with The Associated Press, will receive the National Press Club Journalism Institute's 2023 Neil and Susan Sheehan Award for Investigative Journalism.
  • "We are honored to see her work recognized by the National Press Club Journalism Institute with the Neil and Susan Sheehan Award for Investigative Journalism."
  • As the nonprofit affiliate of the National Press Club, the Institute powers journalism in the public interest.
  • Contact: Beth Francesco, National Press Club Journalism Institute executive director, [email protected]
    View original content to download multimedia: https://www.prnewswire.com/news-releases/kat-stafford-of-the-associated-...

TPI Composites, Inc. Reports Preliminary Estimated Second Quarter 2023 Earnings Results and Provides Updated Guidance for 2023

Retrieved on: 
Wednesday, July 26, 2023

SCOTTSDALE, Ariz., July 26, 2023 (GLOBE NEWSWIRE) -- TPI Composites, Inc. (Nasdaq: TPIC), today announced selected, preliminary estimated financial results for the second quarter ended June 30, 2023, and provided updated guidance for the year ending December 31, 2023.

Key Points: 
  • SCOTTSDALE, Ariz., July 26, 2023 (GLOBE NEWSWIRE) -- TPI Composites, Inc. (Nasdaq: TPIC), today announced selected, preliminary estimated financial results for the second quarter ended June 30, 2023, and provided updated guidance for the year ending December 31, 2023.
  • For the second quarter ended June 30, 2023, we expect:
    (1) See the attached table for the reconciliation of non-GAAP financial data.
  • The selected, preliminary estimated financial results set forth above are unaudited and should be considered preliminary and subject to change.
  • We plan to report our full results for the second quarter in our earnings release and on our earnings call, both of which are scheduled for August 3, 2023.

Hoyer Law Group Secures More Than $600K in Settlements for Federal Employees

Retrieved on: 
Saturday, July 22, 2023

TAMPA, Fla., July 21, 2023 /PRNewswire/ -- Hoyer Law Group proudly announces that attorney Neil Ognibene secured more than $600,000 in settlements for federal government employees within the last year.

Key Points: 
  • TAMPA, Fla., July 21, 2023 /PRNewswire/ -- Hoyer Law Group proudly announces that attorney Neil Ognibene secured more than $600,000 in settlements for federal government employees within the last year.
  • As head of the firm's federal employment practice, Neil specializes in discrimination, harassment, and whistleblower retaliation matters brought on behalf of federal employees.
  • Hoyer Law Group congratulates Neil on his outstanding work and dedication to justice for his federal employee clients.
  • We look forward to continuing to represent federal employees seeking just compensation and nonmonetary remedies for the wrongs they have suffered.

TPI Composites, Inc. Appoints Neil Jones as Chief Quality Officer

Retrieved on: 
Thursday, July 20, 2023

SCOTTSDALE, Ariz., July 20, 2023 (GLOBE NEWSWIRE) -- TPI Composites, Inc., (TPI) (Nasdaq: TPIC) announced today that it has hired Neil Jones as its Chief Quality Officer, effective August 1, 2023.

Key Points: 
  • SCOTTSDALE, Ariz., July 20, 2023 (GLOBE NEWSWIRE) -- TPI Composites, Inc., (TPI) (Nasdaq: TPIC) announced today that it has hired Neil Jones as its Chief Quality Officer, effective August 1, 2023.
  • In this newly-created position, Neil will oversee all quality processes, systems and controls relating to TPI’s wind business and will report directly to TPI’s President and Chief Executive Officer, Bill Siwek.
  • Neil brings over 25 years of experience in quality and engineering positions in the wind and automotive industry.
  • I am confident that Neil will bring fresh insights, innovative ideas, and an unwavering dedication to quality excellence and help enhance the quality culture at TPI.”

Raymond James Ltd. Welcomes Neil Linsdell as Head of Investment Strategy in Canada

Retrieved on: 
Tuesday, May 16, 2023

TORONTO, May 16, 2023 /CNW/ - Raymond James Ltd., the Canadian arm of North American investment dealer Raymond James Financial Inc., today announced that Neil Linsdell has been named Head of Investment Strategy, Private Client Group.

Key Points: 
  • TORONTO, May 16, 2023 /CNW/ - Raymond James Ltd., the Canadian arm of North American investment dealer Raymond James Financial Inc., today announced that Neil Linsdell has been named Head of Investment Strategy, Private Client Group.
  • Mr. Linsdell will focus on delivering value added market insights to assist the firm's clients and advisors with their portfolio solutions.
  • "Neil comes to us with a wealth of experience in the financial markets and is a significant addition to our group," said Christopher Cafley, Senior Vice President Investment Strategy, Products and Trading.
  • The firm also has over 65 research analysts covering more than 1,200 companies in Canada, the United States, and internationally.

ZyVersa Therapeutics Reports First Quarter 2023 Corporate and Financial Results

Retrieved on: 
Friday, May 12, 2023

WESTON, Fla., May 12, 2023 (GLOBE NEWSWIRE) -- ZyVersa Therapeutics, Inc. (Nasdaq: ZVSA; “ZyVersa”), a clinical stage specialty biopharmaceutical company developing first-in-class drugs for treatment of patients with renal and inflammatory diseases who have unmet medical needs, provides a corporate update and reports financial results for the first quarter of 2023 ending March 31, 2023.

Key Points: 
  • “To that end, we welcomed three new members to our Renal Disease Scientific Advisory Board.
  • ZyVersa will need additional financing to support its continuing operations.
  • ZyVersa will seek to fund its operations through public or private equity or debt financings or other sources, which may include government grants and collaborations with third parties.
  • Net losses for the three months ended March 31, 2023 benefited from a $1.0 Million deferred tax benefit compared to none for the year earlier period.

Pixelligent Names Dr. Neil Pschirer as Vice President of Product Development and Strategy

Retrieved on: 
Thursday, May 11, 2023

BALTIMORE, May 11, 2023 (GLOBE NEWSWIRE) -- Pixelligent Technologies today named Dr. Neil Pschirer as Vice President of Product Development and Strategy.

Key Points: 
  • BALTIMORE, May 11, 2023 (GLOBE NEWSWIRE) -- Pixelligent Technologies today named Dr. Neil Pschirer as Vice President of Product Development and Strategy.
  • Neil joined Pixelligent from Optitune, an advanced materials and nanocoating company based in Finland.
  • Before Optitune, Neil spent 15 years at BASF in leadership roles spanning R&D, business development, and strategy.
  • “In addition to extensive materials knowledge and product development experience, Neil brings exceptional “solutions” instincts to Pixelligent,” said President and CEO Craig Bandes.

North American Helium Successfully Brings Sixth Helium Facility into Production

Retrieved on: 
Thursday, May 4, 2023

North American Helium Inc. (“NAH” or the “Company”) today announced a number of updates to the continuing growth of its business.

Key Points: 
  • North American Helium Inc. (“NAH” or the “Company”) today announced a number of updates to the continuing growth of its business.
  • During April 2023 NAH completed construction of, and successfully brought onstream, its sixth helium purification facility near Mankota, Saskatchewan.
  • NAH recently completed two new multi-year sales contracts and has successfully renegotiated several price reopeners on current contracts, at prices that better reflect the current market.
  • To help customers meet critical business requirements during the current global helium shortage, NAH continues to retain uncontracted helium volumes for the spot market as either high-purity gas or liquid.